-
1161
-
1162
Present Evidence of Determinants to Predict the Efficacy of Renal Denervation
Published 2022-01-01Get full text
Article -
1163
-
1164
Current Concepts on Antiplatelet Therapy: Focus on the Novel Thienopyridine and Non-Thienopyridine Agents
Published 2010-01-01Get full text
Article -
1165
-
1166
-
1167
-
1168
Changes in Serum Natriuretic Peptide Levels after Percutaneous Closure of Small to Moderate Ventricular Septal Defects
Published 2012-01-01“…Between 2008 and 2011, 23 patients underwent successfully percutaneous ventricular septal defect closure in 4 cardiology centers. Brain natriuretic peptide levels were measured in nine patients (4 male, mean ages were 25.3±14.3) who underwent percutaneous closure with Amplatzer occluders for membranous or muscular ventricular septal defects were enrolled in the study. …”
Get full text
Article -
1169
Interventional real-time molecular MRI for targeting early myocardial injury in a pig model
Published 2025-02-01Get full text
Article -
1170
Epicardial Fat Tissue: A Potential Marker for Coronary Microvascular Dysfunction
Published 2025-02-01Get full text
Article -
1171
-
1172
-
1173
-
1174
-
1175
Diffuseness of coronary artery disease impacts on immediate hemodynamic and predicted clinical outcomes
Published 2025-01-01Get full text
Article -
1176
Pediatric hypertrophic cardiomyopathy caused by a novel TNNI3 variant
Published 2024-03-01Get full text
Article -
1177
Right Atrial Clot Formation Early after Percutaneous Mitral Balloon Valvuloplasty
Published 2016-01-01Get full text
Article -
1178
-
1179
-
1180
Coronary Microvascular Dysfunction: Insights on Prognosis and Future Perspectives
Published 2025-01-01Get full text
Article